New COVID-19 Cases Are Plummeting—but Don’t Celebrate Just Yet

This hopeful news has two very big caveats.

Experts worry new strains could make vaccines less effective.Michael Ciaglo/Getty

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

The data on COVID-19 hospitalizations and new cases looks better, for a change. After hitting a peak on January 8, the 7-day average case count is down 40 percent, according to the New York Times. Hospitalizations are improving, too, down 24 percent. This isn’t just in a few highly populated states. We’re seeing steep cliffs in new case counts all across the country—half of states have experienced at least a 50 percent drop. 

All of this is promising news. Vaccine distribution, bumbling as the rollout has been, seems to be finally doing some good.

But there are two big caveats.

Yes, for the first time since December 1 2020, hospitalizations are below the 100,000 mark, according to the COVID-19 Tracking Project. But that doesn’t mean ICU beds still aren’t nearly full (or, in the case of the hospital closest to me in the Bay Area, entirely full of 81 COVID-19 patients). There is still the possibility of a healthcare system remaining overly taxed. The peak was so high that any declines need to be taken into context of the horrific rise we saw during the first winter months.

And then there are these new strains. As COVID-19 mutates, scientists have scrambled to track new strains of the disease—potentially more infectious—that could harm the case decline researchers predicted following a projected peak in January. “We’re very worried,” Francis Collins, director of the National Institutes of Health, told the Washington Post. There are variants of the coronavirus from California, from England, and from South Africa (a strain just detected in Baltimore). Research suggests the various vaccines will work on the new strains, but the level of effectiveness for each strain, and for each vaccine, remains unclear.

For now, at least, we have some hope: The trend lines are headed in the right direction.

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

GREAT JOURNALISM, SLOW FUNDRAISING

Our team has been on fire lately—publishing sweeping, one-of-a-kind investigations, ambitious, groundbreaking projects, and even releasing “the holy shit documentary of the year.” And that’s on top of protecting free and fair elections and standing up to bullies and BS when others in the media don’t.

Yet, we just came up pretty short on our first big fundraising campaign since Mother Jones and the Center for Investigative Reporting joined forces.

So, two things:

1) If you value the journalism we do but haven’t pitched in over the last few months, please consider doing so now—we urgently need a lot of help to make up for lost ground.

2) If you’re not ready to donate but you’re interested enough in our work to be reading this, please consider signing up for our free Mother Jones Daily newsletter to get to know us and our reporting better. Maybe once you do, you’ll see it’s something worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate